title: Bilateral lesions of the gustatory thalamus disrupt morphine- but not LiCl-induced intake suppression in rats: evidence against the conditioned taste aversion hypothesis.
abstract: Rats decrease intake of a saccharin conditioned stimulus (CS) when followed by: (1) the administration of an aversive agent such as lithium chloride (referred to as a conditioned taste aversion, CTA); (2) access to a very palatable concentration of sucrose (referred to as an anticipatory contrast effect, ACE); or (3) the administration of a drug of abuse. It is not clear, however, whether the suppressive effects of drugs of abuse are mediated by their aversive or rewarding properties. The present set of experiments addressed this issue by examining the suppressive effects of morphine in rats with a lesion thought to dissociate the two phenomena (i.e., CTA and ACE). The results show that bilateral ibotenic acid lesions of the gustatory thalamus eliminate the suppressive effects of morphine, but fail to disrupt the suppressive effects of the aversive agent, lithium chloride. This pattern of results argues against the CTA account in favor of the reward comparison hypothesis. Specifically, the data suggest that rats suppress intake of a saccharin CS in anticipation of the availability of a preferred drug of abuse and that the gustatory thalamus is essential for this type of reward comparison process.
authors.affiliation: Department of Behavioral Science, Penn State College of Medicine, H181, 500 University Drive, Hershey, PA 17033-2390, USA. psg6@psu.edu
authors.forename: P S
authors.initials: PS
authors.lastname: Grigson
authors.forename: P
authors.initials: P
authors.lastname: Lyuboslavsky
authors.forename: D
authors.initials: D
authors.lastname: Tanase
mesh_terms: D000818:Animals; D018692:Antimanic Agents / Q000494:pharmacology*; D001362:Avoidance Learning / Q000187:drug effects*; D003213:Conditioning, Psychological / Q000187:drug effects; D003714:Denervation; D004326:Drinking / Q000187:drug effects; D018690:Excitatory Amino Acid Agonists; D007051:Ibotenic Acid; D018021:Lithium Chloride / Q000494:pharmacology*; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012439:Saccharin; D013549:Sweetening Agents; D013649:Taste; D013788:Thalamus / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*
chemical_list: D018692:Antimanic Agents; D018690:Excitatory Amino Acid Agonists; D009294:Narcotics; D013549:Sweetening Agents; D007051:Ibotenic Acid; D009020:Morphine; D012439:Saccharin; D018021:Lithium Chloride